How will COVID-19 impact drug funding and reimbursement?
During the ongoing pandemic, the focus on quickly developing COVID-19 vaccines has led countries and global government bodies to make substantial investments...
Mr. Abhishek Kumar is a principal in CRA’s Life Sciences Practice. Mr. Kumar leads strategy projects for Life Sciences clients. His project work has been focused on pricing and market access with additional experience in commercial and portfolio strategy projects.
Within pricing and market access, he has a special interest in pricing strategy, value demonstration and argumentation. He has worked on several key assets helping design their value demonstration platform.
Prior to joining CRA, Abhishek was a Consultant at IQVIA working in their London and Munich offices. He also has industry experience with Sandoz